MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $210,000 | -13.2% | 5,600 | 0.0% | 0.08% | -17.2% |
| Q4 2015 | $242,000 | -0.8% | 5,600 | -13.8% | 0.09% | +72.2% |
| Q3 2015 | $244,000 | -75.7% | 6,500 | -78.0% | 0.05% | -60.6% |
| Q2 2015 | $1,006,000 | -9.5% | 29,600 | -5.7% | 0.14% | -8.7% |
| Q1 2015 | $1,112,000 | -49.1% | 31,400 | -44.0% | 0.15% | -68.3% |
| Q2 2014 | $2,183,000 | -51.7% | 56,100 | -57.5% | 0.47% | -54.0% |
| Q1 2014 | $4,516,000 | +32.2% | 132,091 | -18.9% | 1.03% | +28.1% |
| Q4 2013 | $3,415,000 | +931.7% | 162,787 | +1054.5% | 0.80% | +833.7% |
| Q3 2013 | $331,000 | – | 14,100 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |